C: Use with warning if Rewards outweigh dangers. Animal studies show risk and human experiments not obtainable or neither animal nor human research completed.
pentobarbital will decrease the level or outcome of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Mysterious.
pentobarbital will lower the level or influence of vincristine liposomal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.
This drug may improve the metabolism of estradiol when administered concurrently; patients on oral contraceptives became Expecting when concurrently handled with antiepileptic drugs; advise an alternate contraceptive method to Gals taking this drug
pentobarbital will decrease the level or influence of levoketoconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unfamiliar.
pentobarbital will reduce the level or result of irinotecan liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the level or impact of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advisable; powerful cytochrome P450 enzyme inducers lower systemic exposure to roflumilast and will decrease the therapeutic usefulness
pentobarbital will decrease the level or outcome of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Sturdy CYP3A4 inducers could reduce partiaprevir and ritonavir here stages, and thus lessened efficacy of Viekira Pak
pentobarbital will minimize the level or result of cyclosporine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
Contraindicated (1)pentobarbital will lower the extent or effect of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or result of tinidazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will minimize the extent or effect of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the level or result of nimodipine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Mysterious.
pentobarbital will minimize the extent or result of ramelteon by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.